Unal Mehmet Altay, Bayrakdar Fatma, Fusco Laura, Besbinar Omur, Shuck Christopher E, Yalcin Süleyman, Erken Mine Turktas, Ozkul Aykut, Gurcan Cansu, Panatli Oguzhan, Summak Gokce Yagmur, Gokce Cemile, Orecchioni Marco, Gazzi Arianna, Vitale Flavia, Somers Julia, Demir Emek, Yildiz Serap Suzuk, Nazir Hasan, Grivel Jean-Charles, Bedognetti Davide, Crisanti Andrea, Akcali Kamil Can, Gogotsi Yury, Delogu Lucia Gemma, Yilmazer Açelya
Stem Cell Institute, Ankara University, Balgat, Ankara, Turkey.
Ministry of Health General Directorate of Public Health, Microbiology References Laboratory, Ankara, Turkey.
Nano Today. 2021 Jun;38:101136. doi: 10.1016/j.nantod.2021.101136. Epub 2021 Mar 18.
Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - TiCT, TaCT , MoTiCT and NbCT . To start with antiviral assessment, we first selected and deeply analyzed four different SARS-CoV-2 genotypes, common in most countries and carrying the wild type or mutated spike protein. When inhibition of the viral infection was tested in vitro with four viral clades, TiCT in particular, was able to significantly reduce infection only in SARS-CoV-2/clade GR infected Vero E6 cells. This difference in the antiviral activity, among the four viral particles tested, highlights the importance of considering the viral genotypes and mutations while testing antiviral activity of potential drugs and nanomaterials. Among the other MXenes tested, MoTiCT also showed antiviral properties. Proteomic, functional annotation analysis and comparison to the already published SARS-CoV-2 protein interaction map revealed that MXene-treatment exerts specific inhibitory mechanisms. Envisaging future antiviral MXene-based drug nano-formulations and considering the central importance of the immune response to viral infections, the immune impact of MXenes was evaluated on human primary immune cells by flow cytometry and single-cell mass cytometry on 17 distinct immune subpopulations. Moreover, 40 secreted cytokines were analyzed by Luminex technology. MXene immune profiling revealed i) the excellent bio and immune compatibility of the material, as well as the ability of MXene ii) to inhibit monocytes and iii) to reduce the release of pro-inflammatory cytokines, suggesting an anti-inflammatory effect elicited by MXene. We here report a selection of MXenes and viral SARS-CoV-2 genotypes/mutations, a series of the computational, structural and molecular data depicting deeply the SARS-CoV-2 mechanism of inhibition, as well as high dimensional single-cell immune-MXene profiling. Taken together, our results provide a compendium of knowledge for new developments of MXene-based multi-functioning nanosystems as antivirals and immune-modulators.
被称为MXenes的二维过渡金属碳化物/碳氮化物作为生物医学中的多模态纳米平台正在迅速发展。在此,以严重急性呼吸综合征冠状病毒2(SARS-CoV-2)为模型,我们探索了四种高度稳定且特征明确的MXenes——TiCT、TaCT 、MoTiCT 和NbCT 的抗病毒特性和免疫特征。为了开始抗病毒评估,我们首先选择并深入分析了四种不同的SARS-CoV-2基因型,这些基因型在大多数国家都很常见,携带野生型或突变的刺突蛋白。当用四个病毒分支在体外测试对病毒感染的抑制作用时,特别是TiCT ,仅在感染了SARS-CoV-2/分支GR的Vero E6细胞中能够显著降低感染。在所测试的四种病毒颗粒中,这种抗病毒活性的差异突出了在测试潜在药物和纳米材料的抗病毒活性时考虑病毒基因型和突变的重要性。在测试的其他MXenes中,MoTiCT 也表现出抗病毒特性。蛋白质组学、功能注释分析以及与已发表的SARS-CoV-2蛋白质相互作用图谱的比较表明,MXene处理发挥了特定的抑制机制。设想未来基于MXene的抗病毒药物纳米制剂,并考虑到免疫反应对病毒感染的核心重要性,通过流式细胞术和单细胞质谱流式细胞术对17个不同的免疫亚群评估了MXenes对人原代免疫细胞的免疫影响。此外,通过Luminex技术分析了40种分泌的细胞因子。MXene免疫分析揭示了i)该材料具有出色的生物和免疫相容性,以及MXene ii)抑制单核细胞的能力和iii)减少促炎细胞因子释放的能力,表明MXene引发了抗炎作用。我们在此报告了一系列MXenes和病毒SARS-CoV-2基因型/突变、一系列深入描述SARS-CoV-2抑制机制的计算、结构和分子数据,以及高维单细胞免疫-MXene分析。综上所述,我们的结果为基于MXene的多功能纳米系统作为抗病毒剂和免疫调节剂的新发展提供了知识汇编。